MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells

Lipids in Health and Disease

Volumn 15, Issue 1, 2016, Pages

  Maimaiti, Ailifeire ^a   Maimaiti, Aikebaier ^a   Yang, Yining ^a   Ma, Yitong ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Atherosclerosis; Endothelial cells; Micrornas

Indexed keywords

JANUS KINASE 1; MICRORNA; MICRORNA 106B; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; MIRN106 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANGIOGENESIS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; JAK1 GENE; MAPK14 GENE; PROTEIN EXPRESSION; STAT3 GENE; UPREGULATION; VEGFA GENE; FLOW CYTOMETRY; GENETICS; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

FLOW CYTOMETRY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; STAT3 TRANSCRIPTION FACTOR;

EID: 84960427511     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0216-5     Document Type: Article

References (28)

1. Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardio Res. 2005;65:639-48.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653-60.
3. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48-50.
4. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture. Arterioscler Thromb Vasc Biol. 2005;25:2054-61.
5. O'Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994;145:883-94.
6. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99:1726-32.
7. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-84.
8. Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res. 2009;104:724-32.
9. Petrocca F, Vecchione A, Croce CM. Emerging role miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008;68:8191-4.
10. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004;64:3087-95.
11. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828-33.
12. + cells. Blood. 2007;109(10):4399-405.
13. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006;38:1060-5.
14. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324(5935):1710-3.
15. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13(3):272-86.
16. Semo J, Sharir R, Afek A, et al. The 106b ∼ 25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice. Eur Heart J. 2014;35(45):3212-223.
17. Carraro G, El-Hashash A, Guidolin D, et al. MiR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev Biol. 2009;333(2):238-50.
18. Ye W, Lv Q, Wong CK, et al. The effect of central loops in miRNA: MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One. 2008;3(3):e1719.
19. Doebele C, Bonauer A, Fischer A, et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic, antiangiogenic function in endothelial cells. Blood. 2010;115(23):4944-50.
20. Haura EB, Turkson J, Jove R, et al. Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol. 2005;2(6):315-24.
21. Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002;21(13):2000-8.
22. Long J, Wang Y, Wang W, Chang BHJ, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem. 2010;285(30):23457-465.
23. Kim YK, Yu J, Han TS, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37(5):1672-681.
24. Kim J, Yoon H, Ramírez CM, et al. miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. Exp Neurol. 2012;235(2):476-83.
25. Wu Y, Zuo J, Zhang Y, et al. Identification of miR-106b-93 as a negative regulator of brown adipocyte differentiation. Biochem Bioph Res Co. 2013;438(4):575-80.
26. Trompeter HI, Abbad H, Iwaniuk KM, et al. MicroRNAs miR-17, miR-20a, and miR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One. 2011;6(1):e16138.
27. Sampath D, Calin GA, Puduvalli VK, et al. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 2009;113(16):3744-753.
28. Foshay KM, Gallicano GI. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol. 2009;326(2):431-43.